Abbott Laboratories (ABT)
104.50
-0.22
(-0.21%)
USD |
NYSE |
Nov 18, 16:00
104.40
-0.10
(-0.09%)
After-Hours: 20:00
Abbott Laboratories Enterprise Value : 208.81B for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 208.81B |
| November 16, 2026 | 213.55B |
| November 13, 2026 | 215.41B |
| November 12, 2026 | 213.21B |
| November 11, 2026 | 216.74B |
| November 10, 2026 | 218.77B |
| November 09, 2026 | 218.85B |
| November 06, 2026 | 217.85B |
| November 05, 2026 | 224.21B |
| November 04, 2026 | 227.51B |
| November 03, 2026 | 216.93B |
| November 02, 2026 | 218.25B |
| October 30, 2026 | 211.39B |
| October 29, 2026 | 208.57B |
| October 28, 2026 | 205.22B |
| October 27, 2026 | 206.02B |
| October 26, 2026 | 209.10B |
| October 23, 2026 | 207.06B |
| October 22, 2026 | 205.00B |
| October 21, 2026 | 201.53B |
| October 20, 2026 | 204.89B |
| October 19, 2026 | 207.68B |
| October 16, 2026 | 209.12B |
| October 15, 2026 | 208.76B |
| October 14, 2026 | 205.80B |
| Date | Value |
|---|---|
| October 13, 2026 | 205.17B |
| October 12, 2026 | 203.80B |
| October 09, 2026 | 199.96B |
| October 08, 2026 | 198.04B |
| October 07, 2026 | 198.45B |
| October 06, 2026 | 197.46B |
| October 05, 2026 | 200.82B |
| October 02, 2026 | 196.32B |
| October 01, 2026 | 194.92B |
| September 30, 2026 | 198.62B |
| September 29, 2026 | 202.34B |
| September 28, 2026 | 202.39B |
| September 25, 2026 | 202.93B |
| September 24, 2026 | 202.55B |
| September 23, 2026 | 206.73B |
| September 22, 2026 | 207.08B |
| September 21, 2026 | 205.85B |
| September 18, 2026 | 205.21B |
| September 17, 2026 | 204.55B |
| September 16, 2026 | 204.78B |
| September 15, 2026 | 204.21B |
| September 14, 2026 | 206.04B |
| September 11, 2026 | 204.07B |
| September 10, 2026 | 206.51B |
| September 09, 2026 | 209.75B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Becton, Dickinson & Co. | 74.01B |
| Boston Scientific Corp. | 73.90B |
| Globus Medical, Inc. | 8.876B |
| DexCom, Inc. | 30.18B |
| Intuitive Surgical, Inc. | 145.28B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 920.00M |
| Revenue (Quarterly) | 13.01B |
| Total Expenses (Quarterly) | 12.09B |
| EPS Diluted (Quarterly) | 0.5294 |
| Gross Profit Margin (Quarterly) | 50.36% |
| Profit Margin (Quarterly) | 7.07% |
| Earnings Yield | 2.59% |
| Operating Earnings Yield | 3.77% |
| Normalized Earnings Yield | 2.564 |